The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Analysis on Economic Losses in ESBLs Infected Cases
Author(s): 
Pages: 29-30
Year: Issue:  7
Journal: Chinese Health Economics

Abstract: 目的:为准确了解超广谱β-内酰胺酶(extendspectrumβ-lactamase ESBLs)耐药菌株感染病例所造成的经济损失.方法:采用1:1病例对照研究的方法,调查ESBLs感染病例的直接经济损失,共16对.结果:病例组的住院总费用中位数为29 017.40元,对照组为10 264.01元,病例组是对照组的2.85倍,耐药菌株感染患者多支出住院费用为18 753.40元,平均每例病人多支...
Related Articles
loading...